Radiopharm Theranostics (RAD:AU) has announced First patient dosed in Phase IIb imaging for Brain Mets Download the PDF here. This post appeared first on investingnews.com Prev Post Binding Commitments Received for A$1.0 Million under Convertible Note Placement April 28, 2025 Next Post IBM pledges $150 billion to boost U.S. tech growth, computer manufacturing April 29, 2025 Related Posts Group Eleven Resources Corp. to Attend the 51st Annual New Orleans Investment Conference October 29, 2025 Osisko Intersects 592 Metres Averaging 0.33% Cu at Gaspé October 29, 2025 Metals Focus: Bullish on Platinum, Bearish on Palladium in 2026 October 29, 2025
Group Eleven Resources Corp. to Attend the 51st Annual New Orleans Investment Conference October 29, 2025